Aurobindo To Buy Seven Europe Units Of Actavis For $40.1 Million
This article was originally published in PharmAsia News
Executive Summary
Aurobindo Pharma has a signed a deal to pay $40.1 million for seven European units of Actavis, including their facilities, products and marketing approvals.